Analysis of the SARS-CoV-2 specific immune response in persons with SARS-CoV-2 infection (COVID-19)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023086

Enrollment

190

Registered

2020-10-09

Start date

2020-10-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 COVID-19

Interventions

Group 1: Hospital staff at the time of diagnosis and after recovery or re-entry into Service (Blood test for COVID immunology, blood count and short Anamnesis) Group 2: Patients (immunocompromised and

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients (immunocompromised and immunocompromised) with COVID-19 and controls of both sexes. A broad age spectrum will also be recruited, as the course of the disease varies with age.

Exclusion criteria

Exclusion criteria: No consent of the test person or patient.

Design outcomes

Primary

Measure	Time frame
Achieving the number of cases	—

Secondary

Measure	Time frame
The number of cases is not reached within the defined period. Missing COVID cases.	—

Countries

Germany

Contacts

Public ContactSimon Herkenrath

Krankenhaus Bethanien, gGmbh

simon-dominik.herkenrath@klinik-bethanien.de02 12 / 63 66-62

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026